CVSA · Insider Trading
Covista Inc.
Every open-market purchase and sale reported by CVSA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-16 | Leslie Storms | Director | A | +259 | +$32.96K |
| 2026-10-16 | Sara Hill | CHRO | F | −1,322 | −$168.21K |
| 2026-10-16 | Emily C Chiu | Director | A | +259 | +$32.96K |
| 2026-10-09 | Stephen W. Beard | Chairman & CEO | Sell | −8,306 | −$1.08M |
| 2026-09-01 | Michael W Malafronte | Director | G | −2,500 | — |
| 2026-08-28 | Manjunath Gangadharan | VP, Chief Accounting Officer | Sell | −1,802 | −$247.20K |
| 2026-08-25 | Manjunath Gangadharan | VP, Chief Accounting Officer | MIXED | +1,614 | +$213.61K |
| 2026-08-25 | Stephen W. Beard | Chairman & CEO | MIXED | +62,267 | +$8.24M |
| 2026-08-25 | Robert J. Phelan | Chief Financial Officer | MIXED | +8,265 | +$1.09M |
| 2026-08-25 | Michael Betz | Pres. Walden University & CDO | MIXED | +5,886 | +$779.01K |
| 2026-08-25 | Douglas G. Beck | SVP, GC, Corp. Sec & ISS | MIXED | +4,850 | +$641.90K |
| 2026-08-13 | Stephen W. Beard | Chairman & CEO | Sell | −3,545 | −$462.07K |
| 2026-08-11 | Robert J. Phelan | Chief Financial Officer | Sell | −2,186 | −$295.44K |
| 2026-08-11 | Douglas G. Beck | SVP, GC, Corp. Sec & ISS | Sell | −4,526 | −$614.68K |
| 2026-07-16 | Amelia Manning | President, Chamberlain Univ. | A | +4,317 | +$499.99K |
| 2026-07-15 | Stephen W. Beard | Chairman & CEO | Sell | −5,291 | −$702.40K |
| 2026-07-09 | Robert J. Phelan | Chief Financial Officer | Sell | −5,314 | −$719.50K |
| 2026-07-09 | Douglas G. Beck | SVP, GC, Corp. Sec & ISS | Sell | −5,089 | −$688.91K |
| 2026-06-12 | Stephen W. Beard | Chairman & CEO | Sell | −5,291 | −$690.20K |
| 2026-05-20 | Manjunath Gangadharan | VP, Chief Accounting Officer | F | −426 | −$54.46K |
| 2026-05-12 | Stephen W. Beard | Chairman & CEO | Sell | −15,874 | −$2.08M |
| 2026-05-12 | Douglas G. Beck | SVP, GC, Corp. Sec & ISS | Sell | −9,615 | −$1.22M |
| 2026-05-12 | Karen Sue Cox | President, Chamberlain Univ. | Sell | −2,000 | −$249.00K |
| 2026-05-12 | Robert J. Phelan | Chief Financial Officer | Sell | −10,000 | −$1.26M |
| 2026-04-16 | Scott Liles | President, Medical and Vet | F | −448 | −$50.40K |
| 2026-03-12 | Michael W Malafronte | Director | Buy | +36,036 | +$3.64M |
| 2026-03-05 | Michael W Malafronte | Director | Buy | +1,200 | +$117.56K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Stephen W. Beard | Chairman & CEO | 473,825 | $55.20M |
| Michael W Malafronte | Director | 136,100 | $15.86M |
| Robert J. Phelan | Chief Financial Officer | 54,083 | $6.30M |
| Michael Betz | Pres. Walden University & CDO | 41,483 | $4.83M |
| Douglas G. Beck | SVP, GC, Corp. Sec & ISS | 32,002 | $3.73M |
| Karen Sue Cox | President, Chamberlain Univ. | 31,596 | $3.68M |
| Scott Liles | President, Medical and Vet | 13,103 | $1.53M |
| Sara Hill | CHRO | 8,954 | $1.04M |
| Manjunath Gangadharan | VP, Chief Accounting Officer | 5,083 | $592.17K |
| Amelia Manning | President, Chamberlain Univ. | 4,317 | $502.93K |
| Emily C Chiu | Director | 259 | $30.17K |
| Leslie Storms | Director | 259 | $30.17K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CVSA quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.